[Discussing survey results in client panels appears a beneficial approach for a client counsel]. / Enquêteresultaten bespreken in cliëntenpanels: nuttige aanpak voor cliëntenraad.

BACKGROUND: The Client Participation Act in Healthcare Institutions prescribes that information must be collected as low as possible in the organization. To meet this need, Arkin’s client council started experimenting with a new way to get in touch with clients. METHOD: We regularly send a short survey to clients about a number of themes and we invite clients to discuss these in a client panel. Two rounds of surveys and panel discussions have now been organized on the following themes: waiting times, participation in treatment, stigma, ROM, eHealth and relative or friend. RESULTS: The experiences with the chosen approach were favorable. The collection of quantitative survey data and qualitative information from the panel discussion complemented each other and led to further professionalization of the work of the client council. Clients were happy to be involved in the work of the client council in this way. A better insight was gained into how they experience policy decisions and the client council was better able to present this information to the board of directors and the executive board of Arkin. CONCLUSION: The new approach has strengthened the position of the client council within Arkin. We consider this a good approach to implement the Client Participation Act.

[The PTSD Checklist for DSM-5 (PCL-5): comparing responsivity with the Outcome Questionnaire (OQ-45) and practical utility]. / De PTSS Checklist voor DSM-5 (PCL-5) voor ROM: een vergelijking van de responsiviteit met de Outcome Questionnaire (OQ-45) en praktische bruikbaarheid.

BACKGROUND: The PTSD Checklist for the DSM-5 (PCL-5) may be a suitable addition for routine outcome monitoring (ROM) for patients with PTSD.
AIM: To determine whether the PCL-5 is worth the extra effort that administration requires from the patient.
METHOD: Pretest and retest measurement results of the PCL-5 and the OQ-45 were compared head-to-head in 464 patients from the Sinai Center of Arkin.
RESULTS: The correlations between scores on the instruments were high and analysis of variance for repeated measurements revealed no difference in responsiveness. Comparison of Cohen's d (0.49 vs. 0.43) and Delta T (5.0 vs. 4.4), indicated a slightly better responsiveness of the PCL-5 and also the proportion of recovered patients was greater according to the PCL-5 compared to the OQ-SD.
CONCLUSION: At first glance, the PCL-5 and the OQ-SD were equally sensitive to detect change during treatment. However, the PCL-5 provided more detailed information about the nature and severity of symptomatology in an individual patient and with the PCL-5 we were slightly better able to demonstrate clinical significant change than with the OQ-SD. We recommend to add the PCL-5 to ROM for patients with PTSD.